|
1.
|
Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220–224.
|
|
2.
|
Burkhart CG. Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides. Mayo Clinic Proc. 2004;79:661-666.
|
|
3.
|
Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G. Worldwide prevalence of head lice. Emerg Infect Dis. 2008;14:1493-1494.
|
|
4.
|
CDC. Centers for Disease Control and Prevention. Head lice fact sheet. Available at: http://www.cdc.gov/lice/head/factsheet.html. Accessed October 6, 2009.
|
|
5.
|
Frankowski BL, Weiner LB, the Committee on School Health and the Committee on Infectious Diseases. Pediatr. 2002;110:638–643.
|
|
6.
|
Chang LW, Dyer S. Handbook of neurotoxicology. Available at: http://books.google.com/books?id=jVIfJuUGgR8C&pg=PA481&lpg=PA481&dq=Michael+Farraday+discovers+Lindane&source=bl&
ots=JQDxWozsM_&sig=ERySk9yAhYUC5BLFX_NzMbpZFU&hl=en&
ei=xFuDSqObGJ_FmQe468ShDQ&sa=X&oi=book_result&ct=result&resnum=1#v=onepage&q=&f=false
|
|
7.
|
Cannizzaro reaction. Available at: http://www.absoluteastronomy.com
|
|
8.
|
AAPSE. Pesticide Regulation and Pesticide Education. Available at :http://aapse.ext.vt.edu/archives/97AAPCO_report Accessed on October 6, 2009.
|
|
9.
|
Sneader W. Drug discovery: a history. Available at: http://books.google.com/books?id=mYQxRY9umjcC&dq=Sneader+Drug+Discovery&printsec=frontcover&source=bn&hl=en&
ei=H2GDSt7hOaOntgfdhdnOCg&sa=X&oi=book_result&ct=result&resnum=4#v=onepage&q=Malathion&f=false
|
|
10.
|
Omura S. Review: Ivermectin: 25 years and still going strong. Int J Antimicrob Agents. 2008;31:91–98.
|
|
11.
|
Mectizan Donation Program. History. Available at: http://www.mectizan.org/history
|
|
12.
|
Colatrella B. The Mectizan donation program: 20 years of successful collaboration—a retrospective. Annals of Tropical Medicine & Parasitology. 2008;102:S7–S11.
|
|
13.
|
Head lice: Information and Frequently Asked Questions. Available at:http://www.hsph.harvard.edu/headlice.html
|
|
14.
|
Mumcuoglu KY, Meinking TA, Burkhart CN, Burkhart CG. Head louse infestations: the "no nit" policy and its consequences. Int J Dermatol. 2006;45:891–896.
|
|
15.
|
Clark JM. Invited Review: Determination, mechanism and monitoring of knockdown resistance in permethrin-resistant human head lice, Pediculus humanus capitis. J Asia-Pacific Entomol. 2009;12:1–7.
|
|
16.
|
Lee SH, Clark JM, Ahn YJ, et al. Molecular mechanisms and monitoring of permethrin resistance in human head lice. Article in press.
|
|
17.
|
West DP. Head lice treatment costs and the impact on managed care. Am J Manag Care. 2004;S277–S282.
|
|
18.
|
Burkhart CG, Burkhart CN. Head lice therapies revisited. Dermatology Online Journal. 2006;12:3.
|
|
19.
|
Ovide® (malathion) lotion PI. 2005. TaroPharma. Hawthorne, NY.
|
|
20.
|
Ulesfia PI. 2009. Sciele Pharma. Atlanta , GA.
|
|
21.
|
Benzyl alcohol lotion for head lice. Med Lett Drugs Ther. 2009;51:57-58.
|
|
22.
|
Lindane PI. 2007. Morton Grove Pharmaceuticals, Inc.
|
|
23.
|
CDC. Centers for Disease Control and Prevention. Head lice: Treatment. Available at: www.cdc.gov/lice/head/treatment.html
Accessed on October 7, 2009.
|
|
24.
|
Dymond NL, Swift IM. Permethrin toxicity in cats: a retrospective study of 20 cases. Aust Vet J. 2008;86:219–223.
|
|
25.
|
RID. http://www.ridlice.com Accessed on October 6, 2009.
|
|
26.
|
Geary TG. Ivermectin 20 years on: maturation of a wonder drug. Trend Parasitol. 2005;21:531-532.
|
|
27.
|
Stromectol Tablets PI. 2009. Merck & Co., Inc. Whitehouse Station, NJ.
|
|
28.
|
Data on file. Topaz Pharmaceuticals, Inc. 2008.
|
|
29.
|
Pray WS. Pediculicide resistance in head lice: a survey. Hosp Pharm. 2003;38:241-246.
|
|
30.
|
Gordon SC. Shared vulnerability: a theory of caring for children with persistent head lice. J Sch Nurs. 2007;23:283–292.
|
